Pharmacokinetic and pharmacodynamic modeling of pegylated-interferon alfa

被引:0
|
作者
Dimova, Rositsa B.
Talal, Andrew H. [1 ]
机构
[1] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY 10065 USA
关键词
HEPATITIS-C VIRUS; INFECTED PATIENTS; HCV; RIBAVIRIN; KINETICS; HIV; RESPONSES; EFFICACY; DYNAMICS; THERAPY;
D O I
10.1016/j.jhep.2010.04.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:418 / 420
页数:3
相关论文
共 50 条
  • [41] Erythema Gyratum Repens Induced by Pegylated Interferon Alfa for Chronic Hepatitis C
    Rongioletti, Franco
    Fausti, Valentina
    Parodi, Aurora
    ARCHIVES OF DERMATOLOGY, 2012, 148 (10) : 1213 - 1214
  • [42] Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
    Liu, Yisi
    Zheng, Yanhong
    Lin, Xiao
    Cao, Zhenhuan
    Lu, Junfeng
    Ma, Lina
    Ren, Shan
    Zheng, Sujun
    Hu, Zhongjie
    Xu, Bin
    Chen, Xinyue
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [43] Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients
    Abdel-Moneim, Adel
    Abood, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (03) : 191 - 196
  • [44] Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies
    Xirouchakis, E.
    Triantos, C.
    Manousou, P.
    Sigalas, A.
    Calvaruso, V.
    Corbani, A.
    Leandro, G.
    Patch, D.
    Burroughs, A.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (10) : 699 - 709
  • [45] Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children
    El Naghi, Suzan
    Abdel-Ghaffar, Tawhida Y.
    El-Karaksy, Hanaa
    Abdel-Aty, Elham F.
    El-Raziky, Mona S.
    Allam, Aleef A.
    Helmy, Heba
    El-Araby, Hanaa A.
    Behairy, Behairy E.
    El-Guindi, Mohamed A.
    El-Sebaie, Hatem
    Abdel-Ghaffar, Aisha Y.
    Ehsan, Nermin A.
    El-Hennawy, Ahmed M.
    Sira, Mostafa M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) : 4681 - 4691
  • [46] The expression kinetics of CD137 in chronic hepatitis C patients treated with pegylated-interferon and ribavirin
    Lee, Sang Jin
    Shin, Jung Woo
    Park, Bo Ryung
    Kim, Chang Jae
    Jung, Seok Won
    Kim, Byunggyu
    Jeong, In Du
    Bang, Sung-Jo
    Park, Neung Hwa
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 601 - 606
  • [47] Optimal follow-up time to determine the sustained virological response in patients with chronic hepatitis C receiving pegylated-interferon and ribavirin
    Namikawa, Masashi
    Kakizaki, Satoru
    Yata, Yutaka
    Yamazaki, Yuichi
    Horiguchi, Norio
    Sato, Ken
    Takagi, Hitoshi
    Mori, Masatomo
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (01) : 69 - 75
  • [48] Quantifying the Effect of Methotrexate on Adalimumab Response in Psoriasis by Pharmacokinetic-Pharmacodynamic Modeling
    van Huizen, Astrid
    Bank, Paul
    van der Kraaij, Gayle
    Musters, Annelie
    Busard, Celine
    Menting, Stef
    Rispens, Theo
    de Vries, Annick
    van Doorn, Martijn
    Prens, Errol
    Lambert, Jo
    van den Reek, Juul
    de Jong, Elke
    Mathot, Ron
    Spuls, Phyllis
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (04)
  • [49] Comparative safety and efficacy of conventional interferon versus pegylated-interferon based therapy for HCV: A retrospective cohort study from Gujranwala, Pakistan
    Iftikhar, Usman
    Ahmed, Mobasher
    Saeed, Hamid
    Saleem, Nouman
    Bashir, Afzaal
    Farooq, Muhammad Shahid
    Kamran, Sairah Hafeez
    Saleem, Zikria
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (05) : 2037 - 2045
  • [50] Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis
    Kim, V.
    Abreu, R. M.
    Nakagawa, D. M.
    Baldassare, R. M.
    Carrilho, F. J.
    Ono, S. K.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (03) : 154 - 169